Jump to content
This topic is 1335 days old and is no longer open for new replies.  Replies are automatically disabled after two years of inactivity.  Please create a new topic instead of posting here.  

Recommended Posts

Posted (edited)

image.thumb.png.e327cdf7d3f5dffa42c38a06f8a5af13.png

 

Jan. 14, 2022, 12:23 PM PST
By David K. Li / NBC News

Disgraced drug company executive Martin Shkreli, derided as the “Pharma Bro,” was banned from ever doing business again in the pharmaceutical business, a judge ordered on Friday.

Shkreli was also ordered to pay $64.6 million in profits he scored from hiking the price of the drug Daraprim, U.S. District Court Judge Denise Cote ruled in New York.

 

The court order is tied to a lawsuit, filed by the Federal Trade Commission and several states, including New York and California, that accused the imprisoned Shkreli of monopolistic behavior.

 

As CEO of Turing Pharmaceuticals — later Vyera — Shkreli inflated the price of Daraprim from $13.50 to $750 per pill, after obtaining exclusive rights to the decades-old drug in 2015. Daraprim is needed by those suffering from a rare parasitic disease that strikes AIDS patients, cancer victims and pregnant women.

Edited by glutes
  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...